Propolis, a sticky material that honeybees collect from living plants, has been used for its pharmaceutical properties since ancient times. In this study, we examined the effects of ethanol extracts of Korean propolis (EEKP) from various geographic regions on the inhibition of angiogenesis, both in vitro and in vivo. The effects of EEKP were tested on in vitro models of angiogenesis, that is, tube formation and proliferation of human umbilical vein endothelial cells (HUVECs). All EEKP samples exhibited significant inhibitory effects on tube formation of HUVECs in a concentration-dependent manner (6.25-25 µg/mL). In addition, two EEKP samples, prepared from Uijeongbu and Pyoseon propolis, significantly suppressed the proliferation of HUVECs in a concentrationdependent manner (3.13-25 µg/mL). Furthermore, in an in vivo angiogenesis assay using the chick embryo chorioallantoic membrane (CAM) system, we found that the two EEKP samples significantly reduced the number of newly formed vessels. These results indicate that Korean propolis may have potential applications in the prevention and treatment of angiogenesis-related diseases such as cancer.
Angiogenesis, or new blood vessel growth, is defined as the process in which a network of new blood vessels emerges from preexisting vessels [1] . Exponential tumor growth over a few mm 3 in size is dependent on the recruitment of such new blood vessels through angiogenesis for nutrition and oxygen [2] . Angiogenesis is also essential for tumor growth and metastasis, and tumor angiogenesis is a promising target for cancer prevention and treatment [3] . It is expected that antiangiogenic food factors, if found, would be useful to prevent progression of small cancers and several other diseases.
Propolis, a natural resinous substance with a complex composition, is collected by honeybees from various sprouts, plant exudates, buds and leaves and is modified in their hives. It has been used in folk medicine from ancient times for its pharmaceutical properties and has been extensively studied in many countries [4, 5] . It is reported to possess various biological activities, such as antibacterial [6, 7] , antiviral [6, 8] , antifungal [6, 9] , antiinflammatory [10] , antihepatotoxic [11] , anticancer [12, 13] , antitumor [14, 15] , and antimutagenic [16] properties. For these reasons, it is extensively used in foods, beverages, and dietary supplements to improve health and to prevent diseases [5, 17] .
In our previous paper, we reported that Brazilian propolis and its major component artepillin C possess antiangiogenic activities based on in vitro and in vivo angiogenesis models [18] . We also found that Brazilian propolis suppresses angiogenesis by inducing apoptosis in tube-forming endothelial cells through inactivation of one of the major survival signals, extracellular signal-regulated kinase 1/2 (ERK 1/2) [19] . Furthermore, we have been extensively studying the biological activities and components of propolis from around the world [18, [20] [21] [22] [23] [24] . Propolis usually contains a variety of chemical compounds, such as polyphenols (flavonoids, phenolic acid, and their esters), terpenoids, steroids, and amino acids, but its composition differs qualitatively and quantitatively depending upon its geographical and botanical origins [25] . The chemical composition and biological activity of propolis have been studied extensively in many countries, but only a few reports can be found on Korean propolis. We recently reported the antioxidant activities and the chemical compositions of propolis from various areas of Korea [21] . Kim et al. reported that Korean propolis exhibited antimicrobial effects against foodborne pathogens and spores of Bacillus cereus [26] . Eom et al. found that Korean propolis inhibited the proliferation of human leukemia HL-60 cells and induced apoptosis through the mitochondrial pathway [27] . However, there have been only a limited number of reports concerning the antiangiogenic effects of propolis and no reports on the effects of Korean propolis on angiogenesis in vitro and in vivo.
In this study, we investigated the antiangiogenic activities of the ethanol extracts of Korean propolis (EEKP) of various geographic origins ( Figure 1 ). We analyzed the effects of EEKP on angiogenesis in vitro through inhibition of tube formation and endothelial cell proliferation. Furthermore, we used the chick embryo chorioallantoic membrane (CAM) assay system to evaluate the in vivo angiogenic activity of EEKP.
Figure 2:
Inhibitory effects of Korean propolis on tube formation of endothelial cells (P1-P9). Cells were sandwiched between two layers of collagen gel at a density of 6.0 × 10 4 cells/cm 2 and induced to form blood vessel-like tubes. The experiment was repeated three times and representative data are shown. HUVECs were seeded and cultured between two collagen gel layers in the presence of various concentrations of EEKP (control, 6.25, 12.5, and 25 μg/mL). Bar indicates 100 μm.
Inhibition of HUVEC tube formation by Korean propolis:
We investigated the in vitro and in vivo antiangiogenic activities of the ethanol extracts of propolis (EEKP) from all provincial regions in Korea. We first examined the effect of EEKP on the morphology of capillary tubes using an in vitro tube formation model of HUVECs cultured in a two-dimensional system. During normal tube formation, the endothelial cells migrated and gathered together, then became elongated and adhered to each other to form a network of capillary-like tubes.
Each EEKP sample (P1-P9) showed varying degrees of inhibitory effects on tube formation of endothelial cells in a concentrationdependent manner ( Figure 2 ). EEKP from Uijeongbu (P1) had a strong inhibitory effect on tube formation. It disturbed tube morphology and caused slight fragmentation of the network at 6.25 µg/mL. It almost completely inhibited elongation of the cells at 12.5 µg/mL. It induced death of most cells at 25 µg/mL. EEKP samples from Hongcheon (P2) and Chungju (P3) had a weak inhibitory effect and endothelial cells were able to form capillary-like tubes almost normally at 6.25 µg/mL. These samples slightly reduced the width of the tubes and caused partial fragmentation of the capillary network at 12.5 µg/mL and completely inhibited elongation of the cells at 25 µg/mL. EEKP samples from Cheonan (P4), Iksan (P5), Jangseong (P6), Sangju (P7), and Changnyeong (P8) had a mild inhibitory effect. These samples slightly reduced the width of the tubes at 6.25 µg/mL, further reduced their width and caused modest fragmentation of the network at 12.5 µg/mL and completely inhibited elongation of the cells at 25 µg/mL. EEKP from Pyoseon (P9) had the strongest inhibitory effect among all the Korean propolis we tested. It reduced the width of the tubes and caused extensive fragmentation of the network at 6.25 µg/mL. It almost completely inhibited elongation of the cells and induced cell death in nearly half of them at 12.5 µg/mL. It further induced cell death in most cells at 25 µg/mL. Therefore, we decided to focus our study on the inhibition of angiogenesis by EEKP from Uijeongbu (P1) and Pyoseon (P9), since EEKP from Pyoseon (P9) had the strongest inhibitory effect and that from Uijeongbu (P1) had the second strongest effect. The tube areas were 35.9%, 25.1%, 18.7%, 15.2%, 22.1%, 15.7%, and 12.0% for control, and those with EEKP from P1 (6.25, 12.5, and 25 µg/mL) and P9 (6.25, 12.5, and 25 µg/mL) were calculated to be 69.7%, 50.5%, 42.4%, 62.4%, 41.3%, and 33.1%, respectively, compared with the control (Figure 3) . Similar results were observed in other experiments ( Figure 4A and 4B). The total area occupied by the tube-like structures of endothelial cells decreased significantly as a function of increasing concentrations of EEKP compared with the control ( Figure 4B ). EEKP significantly inhibited tube formation in a concentration-dependent manner. These findings are consistent with the stronger in vitro antiangiogenic effect of EEKP from Pyoseon (P9) than from Uijeongbu (P1).
Inhibition of HUVEC proliferation by Korean propolis:
We then investigated the effects of two Korean propolis samples (P1 and P9) on endothelial cell proliferation in another in vitro model of angiogenesis ( Figure 5 ). EEKP from P1 (3.13, 6.25, 12.5, and 25 µg/mL) significantly reduced cell proliferation to 95.4%, 77.9%, 30.7% and 5.5%, respectively, compared with the control, while EEKP from P9 at the same concentrations also significantly reduced the rates to 58.5%, 53.5%, 9.3% and 1.1%, respectively. Thus, EEKP samples from Uijeongbu (P1) and Pyoseon (P9) significantly suppressed the proliferation of HUVECs in a concentrationdependent manner, with a projected IC 50 of 8.3 and 6.9 µg/mL, respectively. These results demonstrated that EEKP samples have antiangiogenic activities via the inhibition of endothelial cell proliferation. 
Suppression of chorioallantoic membrane angiogenesis by Korean propolis:
To further evaluate the effects of Korean propolis on angiogenesis in vivo, we performed a chick CAM assay.
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Retinoic acid (5 nmol/egg), which is known to have antiangiogenic activity, was used as a positive control [28] . EEKP samples (6.25-25 µg/egg) significantly inhibited new blood vessel growth of chick embryos and suppressed embryonic angiogenesis in a dosedependent manner (Figure 6 ). At a concentration of 25 µg/egg, EEKP samples showed relatively similar antiangiogenic effects compared with those of retinoic acid. EEKP from Pyoseon (P9) had stronger antiangiogenic activity in vivo than that from Uijeongbu (P1). Angiogenesis rates were 77.4% for retinoic acid and 45.8%, 60.9%, and 72.9% for EEKP from Pyoseon (P9) (6.25, 12.5, and 25 µg/egg), respectively, compared with the negative control. However, the branching pattern of blood vessels in a 25 µg/egg Pyoseon (P9)-treated CAM was not significantly different from that of retinoic acid.
In the present study, we investigated the antiangiogenic activity of the ethanol extracts of Korean propolis (EEKP) from various geographic origins. Although some researchers have reported that propolis possesses various biological activities, there have been only a limited number of reports concerning the antiangiogenic effects of propolis and no reports on the antiangiogenic effects of Korean propolis. When the areas of all tubes constructed in the 2-D culture model were measured, all EEKP samples (P1-P9) were shown to inhibit tube formation of HUVECs significantly, in a concentration-dependent manner (6.25-25 µg/mL). EEKP samples from Uijeongbu (P1) and Pyoseon (P9) had the strongest and second strongest inhibitory effects, respectively, and also inhibited proliferation of HUVECs in a concentration-dependent way (3.13-25 µg/mL). Furthermore, the two EEKP samples showed significant antiangiogenic effects in CAM assays, significantly reducing the number of newly formed vessels. To our knowledge, this is the first report that describes the antiangiogenic activity of Korean propolis using in vitro and in vivo models.
Propolis is a resinous substance collected by honeybees from various plant sources. The composition of propolis depends on the specific local flora at the site of collection and thus on the geographic and climatic characteristics of the site, and their biological activities also vary considerably [6, 7, 20, 25, 29] . We recently examined the antioxidant activities and chemical compositions of propolis from all provincial regions in Korea [21] . Every sample (P1-P8) had relatively strong antioxidant activities, except the one from Pyoseon (P9), which is located in southern Korea, distant from all the other sample regions. We further confirmed that the chemical constituents of the ethanol extract of Pyoseon (P9) differ from those of Uijeongbu (P1). EEKP from Uijeongbu (P1) contains many kinds of flavonoids and phenolic acid esters, and its main origin is Populus spp. On the other hand, EEKP from Pyoseon (P9), a subtropical region, has a different composition from Populus-type propolis, and its plant source is currently unknown. EEKP from Pyoseon (P9) was shown to possess relatively weak antioxidant activity, but strong antiangiogenic activity in this study. Research on the active components in propolis from Pyoseon (P9) is in progress.
Propolis is composed of more than 150 chemicals, and those from Europe and non-tropical regions of Asia contain many kinds of flavonoids and phenolic acid esters [4, [20] [21] [22] . Flavonoids and other phenolic substances have been suggested to play a preventive role in the development of cancer and heart disease [30] . Banskota et al. found that the antioxidative activity of propolis is due to its phenolic components, which also possess antitumor and antihepatotoxic activities [5, 11] . For instance, various pharmacological activities of quercetin have been demonstrated, including antioxidant effects by scavenging free radicals, prevention of atherosclerosis and chronic inflammation, and antiangiogenic activities [31] [32] [33] . Caffeic acid phenethyl ester (CAPE), a bioactive component of propolis, has also been reported to possess preferential cytotoxicity against tumor cells [34, 35] . Many researchers have reported that short exposure to CAPE causes a significant drop in intracellular glutathione levels in tumor cells, but not in normal cells, indicating that CAPE might be a pro-oxidant for cancer cells and an antioxidant for normal cells [36, 37] . We also reported a significant correlation between antiangiogenic activity and antioxidant activity in various components from propolis [38] . Components from propolis with high antiangiogenic activity, such as CAPE, galangin, kaempferol, and quercetin, also have been shown to possess high antioxidant activity. These components might be responsible, at least in part, for the antiangiogenic activity of EEKP in vivo.
Angiogenesis plays an important role in tumor growth, and blocking the process of angiogenesis may restrict this [1, 39] . The CAM assay has been a model for studying angiogenesis since the early 1970s when it was adapted by Folkmann et al. [1] . It is widely utilized as an in vivo system for studying both angiogenesis and antiangiogenesis. In this study, we also used the CAM assay system to evaluate the in vivo antiangiogenic activity of EEKP. There was a marked reduction of normal branching patterns of blood vessels following treatment of CAM with retinoic acid and EEKP ( Figure  6 ). These findings indicate that EEKP could be active against CAM neovascularization. Many studies have been conducted to discover various food factors that could be used in the prevention and/or treatment of cancer. A wide array of phenolic compounds has been reported to target and inhibit several key events of the angiogenic process [40] . We and other investigators have shown that food factors, such as artepillin C, galangin, resveratrol, quercetin and indole-3-carbinol, possess antiangiogenic activities [18, 33, 38, 41] . Kim et al. reported that caffeic acid is a potent antiangiogenic agent that effectively inhibits retinal neovascularization without retinal toxicity [42] . Wang et al. found that cafestol, a coffee diterpene, is a potent antiangiogenic phytochemical that exerts effects on several molecular processes during angiogenesis [43] . Thus, finding new food factors with antiangiogenic activity provides beneficial clues for the development of new drug and functional food candidates.
The results of the present study indicate that Korean propolis possesses strong antiangiogenic activity both in vitro and in vivo. Therefore, Korean propolis may have the potential to be developed into pharmaceutical drugs for the prevention and treatment of angiogenesis-related diseases. We plan to investigate further the mechanism of inhibition of angiogenesis by EEKP at cellular and molecular levels.
Experimental
Materials: MCDB-104 medium was purchased from Nihon Pharmaceutical (Tokyo, Japan), fetal bovine serum (FBS) from Moregate (Brisbane, Australia), atelocollagen bovine dermis (type I collagen) from Koken (Tokyo, Japan), epidermal growth factor (EGF) from BD Biosciences (Bedford, MA), and human basic fibroblast growth factor (bFGF) (Recombinant) from Austral Biologicals (San Ramon, CA, USA). Unless otherwise stated, all chemicals were purchased from Sigma (St. Louis, MO, USA). Fertilized chicken eggs were obtained from Pulmuone Farm (Danyang, Korea). Fat emulsion (20%) was from Green Cross Pharmacy Co. (Seoul, Korea).
Experimental sample preparation:
Propolis samples were collected from various areas of Korea and extracted, as previously reported [21] . Figure 1 shows the collection sites for all samples. In brief, the
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Natural Product Communications Vol. 9 (4) 2014 559 crude propolis materials (100 mg each) were extracted with ethanol (3 mL) at room temperature for 24 h. The ethanol suspension was separated by centrifugation at 470 g for 15 min at 25°C; the supernatant was concentrated in a rotary evaporator under reduced pressure at 40°C until reaching a constant weight, and then redissolved in ethanol. The preparation obtained was named ethanol extracts of Korean propolis (EEKP) and was brown in color. EEKP was stored under dry conditions at 4°C until analyzed.
Cell culture: Human umbilical vein endothelial cells (HUVECs) were grown in HUVEC growth medium (MCDB-104 medium supplemented with 10 ng/mL EGF, 100 µg/mL heparin, 100 ng/mL endothelial cell growth factor, and 10% FBS), as previously reported [18] . The cells were seeded on plates coated with 0.1% gelatin and allowed to grow to sub-confluence at 37°C. HUVECs of passages 5-8, equivalent to population doubling levels of 18.9-30.9 in actively growing conditions were used for experiments.
Tube formation assay:
HUVECs were induced to form capillary tube-like structures in type I collagen gel (Cellgen), as previously described, with slight modifications [18, 38] . Briefly, HUVECs (6.0 × 10 4 cells/cm 2 ) were seeded between two layers of collagen gel (0.21% collagen) and incubated in MCDB-104 supplemented with 0.5% FBS, 10 ng/mL bFGF, 8 nM/mL phorbol 12-myristate 13acetate, and 25 µg/mL ascorbic acid. They were treated with various concentrations of EEKP (6.25, 12.5, and 25 µg/mL) for up to 24 h. The tube morphology was photographed at the indicated time. The tube formation was quantified by determining the pixel number of the tubes in each image using the NIH Image program.
Quantification of structures formed by endothelial cells:
For morphological observation, the tube-forming HUVECs were fixed with 2% glutaraldehyde in phosphate-buffered saline solution (PBS) and then stained with 0.1% toluidine blue in 30% methanol. After washing with water, the stained tube morphology was directly observed without phase contrast. Five microscopic fields per well were recorded. The area of tube-formed cell structure was quantified by using the NIH Image program.
Measurement of proliferation inhibition of cells:
HUVECs were seeded onto gelatin-coated 24-multiwell plates at a density of 1.0 × 10 4 cells/cm 2 in HUVEC growth media. After 24 h incubation at 37°C in a 5% CO 2 incubator, EEKP was added to the wells (3.13, 6.25, 12.5, and 25 µg/mL) and the cells were further cultured for 48 h. The number of cells was counted with a Coulter Counter (Coulter Electronics, Hialeah, USA).
Chick embryo chorioallantoic membrane assay:
In vivo angiogenic activity of Korean propolis was assayed using chick embryo chorioallantoic membrane (CAM). The CAM assay was performed as described previously with slight modifications [28, 44] . Briefly, fertilized chicken eggs were kept in a humidified incubator at 37°C. After 6 days of incubation, approximately 4 mL of albumin was aspirated from the eggs with an 18-gauge hypodermic needle through a small hole drilled at the narrow end of the eggs, allowing the small CAM and yolk sac to drop away from the shell membrane. Onto 7-day-old fertilized chicken embryos in the shells, 10 µL aliquots of EEKP samples (6.25, 12.5, and 25 µg/egg) or retinoic acid (5 nmol/egg), as a positive control mixed in 1% methylcellulose /0.9% NaCl, were applied into 2 mm silicon rings placed on the surface of the growing CAM. After 2 days incubation, an appropriate volume of a 20% fat emulsion was injected into the CAM to visualize the blood vessels. At least 20 eggs were used for each condition, and experiments were repeated 5 times. The results were expressed as a suppression ratio of new vessel within the area encircled by a white ring. The antiangiogenesis rates were calculated using the following equation: AR (%) = {1 -(CS / SC)} × 100 where AR is the antiangiogenesis rate, CS is the control score, and SC is the sample score. The score point is ranked as follows: (-) no inhibition, 0 point; (±) barely detectable inhibition of capillary vessels, 1 point; (+) apparent partial inhibition capillary vessels, 2 points; (++) complete inhibition of capillary vessels, 3 points; (+++) inhibition of large vessels, 4 points.
Statistical analysis:
Results were presented as mean ± SE obtained from either 3 or 5 independent experiments. Data were evaluated statistically using one-way analysis of variance (ANOVA) followed by Holm-Sidak method and using Student t-test for analysis between control and treatments. Statistical significance was preset at *P < 0.05.
